NCT06545331
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06545331
Title Study of XB010 in Subjects With Solid Tumors
Acronym DELTA-101
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Exelixis
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Exelixis Clinical Site #4 RECRUITING Duarte California 91010 United States Details
Exelixis Clinical Site #10 RECRUITING Washington D.C. District of Columbia 20007 United States Details
Exelixis Clinical Site #12 RECRUITING Atlanta Georgia 30322 United States Details
Exelixis Clinical Site #5 RECRUITING St Louis Missouri 63110 United States Details
Exelixis Clinical Site #3 RECRUITING Huntersville North Carolina 28078 United States Details
Exelixis Clinical Site #6 RECRUITING Oklahoma City Oklahoma 73104 United States Details
Exelixis Clinical Site #9 RECRUITING Nashville Tennessee 37203 United States Details
Exelixis Clinical Site #1 RECRUITING Austin Texas 78758 United States Details
Exelixis Clinical Site #7 RECRUITING Dallas Texas 74246 United States Details
Exelixis Clinical Site #8 RECRUITING Houston Texas 77030 United States Details
Exelixis Clinical Site #11 RECRUITING Fairfax Virginia 22031 United States Details
Exelixis Clinical Site #2 RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field